Navigation Links
Ingenious Med Reports Record Sales and Client Expansions in 2007
Date:2/5/2008

ATLANTA, Feb. 5 /PRNewswire/ -- Ingenious Med, leaders in software and services for improving inpatient charge capture and practice management, announces record sales, product deployments, partnerships, and client expansions in 2007. At year end, Ingenious Med's 2007 sales increased by 81% over 2006. This increase in sales coupled with strong margins led to a dramatic increase in IM's overall profitability.

In the past year, Ingenious Med secured 38 new IM Practice Manager(TM) contracts representing a wide spectrum of clients such as large healthcare systems, national management companies, academic institutions, standard physician practices, and medical billing companies. New customers include groups such as: Kelsey-Seybold, University of Colorado, Asante Health System, Quincy Medical Center, St. Lukes Kansas City, Midstate Medical Center and Millennium Management Company.

Ingenious Med now has clientele in 39 states and is currently in use at over 500 healthcare facilities across the nation. Last year, the company's flagship product, IM Practice Manager(TM), captured and managed approximately $135 million in physician charges.

In addition to a 95% retention rate, the company experienced outstanding client expansion in 2007. Clients who expanded their user base with Ingenious Med include TeamHealth, Valley Baptist Medical Center, Cooley Dickinson Practice Associates, and TSG Resources, Inc.

"Our continued growth and retention over the past year are strong indicators of the quality and success of our services. Customers typically realize a $35,000 to $45,000 increase in net revenue per physician annually. That is an exceptional return on investment that easily equates to more than 1000-2000% for many clients," said Steven Liu, MD, CEO of Ingenious Med. "This has had a dramatic effect on new sales and referrals and has led to the expansion of our services into more than a dozen new specialties. Although we were originally developed f
'/>"/>

SOURCE Ingenious Med
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. Haemacure Reports Third Quarter 2007 Results
4. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
5. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
6. MDS Reports Third Quarter 2007 Results
7. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
8. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
9. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
10. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
11. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
... Carolina at Chapel Hill have managed to isolate a...s in Cystic Fibrosis. Blocking this// system allow... thus may herald in new treatments for the disease...isease caused by a defective gene that produces a ...
...though they do not develop zits, the do have oily ... to differentiate the cells// in the sebaceous gla...search examines how a sebaceous gland is formed. ...st 11 issue of Cell, Elaine Fuchs, a Howard Hughes...
...leptic son in July 2004 has for the first time spo...ess, Carmichael who is at the Brockville// Psychia...ories. "I wouldn't want any family to go through ...rry. I miss my son very much." Carmichael was a ph...
...st condom manufacturing unit in the country, is al...ncludes a vibrating ring plus a condom, a three-in...ceptive for women," said HLL chairman cum managing...porters here, Friday. Initially all these product...
Other Medicine News:Health News:Cellular System Causing Destruction Of Faulty Proteins In Cystic Fibrosis Identified 2Health News:'Blimp1' Gene Linked To Oily Skin 2
(Date:9/4/2008)... real-time PCR testing for the diagnostic ... Sept. 4 /- The U.S. Food & Drug,Admi...aqMan(R) HBV Test,the first assay for quantitatin...est uses Roche,s real-time PCR technology to quant...nt,s blood. Doctors may use viral load,testing res...
(Date:9/4/2008)...r 4 /- Axentis Pharma AG has,initiate...and tolerability,of a new therapeutic formulation ... cystic fibrosis patients. The new formulation all...ed directly to the site of,infection. The forthcom...ferent doses of the new drug. Initial results are ...
(Date:9/3/2008)...inhua--,Pharmaceutical comp...nced,that it has enrolled the first subject into i...g Bronchitol in cystic fibrosis sufferers., The P...ross North,America, Argentina and Germany, and is ...roval to market Bronchitol for cystic fibrosis in ...
(Date:9/3/2008)...Vascular Disease Awareness Month, CHARLOTTESVILLE...ticals,LLC, a clinical-stage drug-development comp... unmet medical needs, announced today that it has ...trial of its lead drug,candidate trans sodium croc...n the clinicaltrials.gov Website, is investigating...
Breaking Medicine Technology:FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Molecular glue with new effect 10629 1Molecular glue with new effect 10629 2Webcast Alert 3A HCA Announces 4Q Year End 07 Earnings Report 10628 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 1Dako Selects Axeda for Remote Monitoring Reporting and Software Management of Cancer Diagnostic System 10625 2Healthcare Technologies Ltd Announces the Change of its Name to 22NexGen Biofuels Ltd 22 2902 1
... 14, 2007 /PRNewswire-FirstCall/ -- Shire plc ,th...t/Hyperactivity,Disorder (ADHD), announced that it...tment portfolio at the American Psychiatric,Associ... in San,Diego. , "The upcoming clinical research t... to understanding the science of ADHD treatment,",...
...NESS WIRE)--May 15, 2007 - Gemin X Biotechnologies...he journal Blood,demonstrated that its lead compou...tro in Mantle Cell Lymphoma (MCL) cell lines and,p...-070) is a small,molecule specifically designed to... family, a validated cancer target, thus restoring...
Other Medicine Technology:Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 2Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 3Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 4Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 5Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 6Shire to Present New Scientific Data on ADHD Treatment Portfolio at,APA Annual Meeting 7Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3
...ries Freezing Stages fit easily onto most microtom...arts and need only the AC supply and a trickle of ...ediately and can be maintained indefinitely. Stag...g temperatures can be set for different kinds of t...
ELISA kit for the quantitative determination of autoantibodies to glutamic acid decarboxylase (GAD65) in serum
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum
RIA kit for the quantitative determination of autoantibodies to insulin in serum
Medicine Products: